TCL Archive Board approves continuation of partnerships between minority institutions and cancer centers for research, training, and outreach. July 9, 2004
TCL Archive NCI Advisors Approve $160-Million Network For Biomarker Discovery, Validation March 13, 2009
TCL Archive Phase III Trial of Imbruvica Halted, Following Increases in Progression-Free Survival January 31, 2014